Shijie Jia Selected Research

Breast Neoplasms (Breast Cancer)

2/2024	Association between Homologous Recombination Repair Defect Status and Long-Term Prognosis of Early HER2-Low Breast Cancer: A Retrospective Cohort Study.
6/2023	Association of FTH1-Expressing Circulating Tumor Cells With Efficacy of Neoadjuvant Chemotherapy for Patients With Breast Cancer: A Prospective Cohort Study.
1/2022	circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shijie Jia Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2022
1	Neoplasms (Cancer) 02/2024
1	Circulating Neoplastic Cells 06/2023
1	Infections 01/2023
1	Reinfection 01/2023
1	COVID-19 01/2023
1	Hepatitis D 01/2023
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Chronic Hepatitis B 01/2019
1	Stroke (Strokes) 06/2014
1	Acute Kidney Injury (Acute Renal Failure) 02/2010

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2021
1	Epidermal Growth Factor (EGF)IBA 02/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	VaccinesIBA 01/2023
1	Circular RNAIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Interferon-alpha (Interferon Alfa)IBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019

Therapy/Procedure

1	Neoadjuvant Therapy 06/2023
1	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 06/2014
1	Extracorporeal Membrane Oxygenation 02/2010